TOP STORIES

• REGULATORY Japan Unveils 1,095 Off-Patent Branded Drugs Subject to New Coverage Rule
  April 23, 2024

• REGULATORY MHLW Proposes Simplified Generic Delisting Scheme
  April 22, 2024

• REGULATORY More Unexpected Substances in Kobayashi’s Beni-Koji Supplements: MHLW
  April 22, 2024

• REGULATORY MHLW Panel Sets Topics for PMD Act Amendment; Pediatrics, Drug Loss on Agenda
  April 19, 2024

• ORGANIZATION Doctors’ Lobby Objects MOF Proposal for CEA Use in Reimbursement Decisions
  April 18, 2024

• REGULATORY MOF Ramps Up Push for Use of Cost-Effectiveness Assessment in Reimbursement Decisions
  April 17, 2024

• BUSINESS Moderna to File mRNA RSV Vaccine in Japan within 2024: Exec
  April 17, 2024

• REGULATORY PMDA Stepping Up Generic Compliance Inspections from August Approvals
  April 16, 2024

• BUSINESS 80%-Plus Doctors Seek In-Person Meetings with Reps: Lilly Survey
  April 16, 2024

• REGULATORY Japan Might Approve 1st Eylea Biosimilar by June, but Not AMD Use
  April 15, 2024

• BUSINESS Wholesaler Purchase Prices of Unprofitable Drugs on Upward Trend after FY2024 Revision
  April 12, 2024

• BUSINESS Moderna Plots Successive Launches in Japan, Updated COVID Jab by Fall: Medical Chief
  April 11, 2024

• REGULATORY Alexion’s Voydeya Marks 1st Application of “Early Launch Premium,” but Rate Fully Axed
  April 11, 2024

• REGULATORY Lagevrio to Get 8.2% Price Cut in July, 2.7% for Kerendia: CEA
  April 11, 2024

• REGULATORY LDP Healthcare Clique Urges Rethink of Rationale for Off-Year Drug Price Revisions
  April 10, 2024

• BUSINESS R&D Jobs Make Up 40% of Pharma New Grads Hires This Spring, Sales Reps Only 20%: Poll
  April 9, 2024

• ORGANIZATION JPMA Launches Website Listing R&D Policies of Members to Help Foster Innovation Ecosystem
  April 9, 2024

• BUSINESS GSK Japan Shooting for 80% Goal for Paid Paternity Leave in 2024
  April 8, 2024

• BUSINESS Kyowa Kirin Hopes Amgen-Partnered Eczema Drug to Rival or Even Eclipse Crysvita in Sales: CEO
  April 5, 2024

• ORGANIZATION PhRMA Hails 2024 Reform, but Says Full Picture Unchanged as 50% of Patented Meds Still Face Cuts
  April 4, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• …
• Next ›
• 最終 »